CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures?Investors Business Daily • 10/20/22
Strength Seen in Amgen (AMGN): Can Its 5.7% Jump Turn into More Strength?Zacks Investment Research • 10/12/22
Amgen (AMGN) Crossed Above the 200-Day Moving Average: What That Means for InvestorsZacks Investment Research • 10/12/22
AMGEN'S ANNUAL TRENDS REPORT FINDS COMPETITION CREATED BY BIOSIMILARS CONTRIBUTED $21 BILLION IN U.S. HEALTHCARE SYSTEM SAVINGSPRNewsWire • 10/12/22
Stock Market Succumbs To Late Selling Again Ahead Of Inflation Data, Fed Minutes, Retail SalesInvestors Business Daily • 10/11/22
Amgen, The Big Name You Need To Know Going Up Against Novo, Lilly In ObesityInvestors Business Daily • 10/11/22
Amgen stock surges, provides nearly 80-point support to the Dow after Morgan Stanley turns bullishMarket Watch • 10/11/22
AMGEN OPENS NEW STATE-OF-THE-ART RESEARCH AND DEVELOPMENT LABORATORY SITE IN SAN FRANCISCO BAY AREAPRNewsWire • 10/06/22
MDA Breakout Stocks Week 39 - September 2022: Short-Term Picks To Give You An EdgeSeeking Alpha • 09/26/22